IVA Icon

$IVA

$IVA

Inventiva

Inventiva is a France-based clinical-stage biopharmaceutical company developing treatments for metabolic dysfunction-associated steatohepatitis (MASH) and other fibrotic diseases.

Stocks

Total Asset Value

$< 0.001

Holders

0

Monthly Transfer Volume

$0.00

Inventiva Metrics

Tokenized Public Stocks

10 Total